ArticleBiophysical journal2025
Disease-related miRNA mutations are associated with mature miRNA secondary structure changes.
Article in Biophysical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MicroRNAs (miRNAs) are ubiquitous short RNAs regulating gene expression in many organisms, including humans. How the secondary structure (SS) of a mature miRNA affects its regulatory function remains an open question. Here, we investigate this question through computational SS predictions of miRNA point mutants. We explore the mutational neighborhoods of miRNAs with association to human diseases, including cancer. We focus on possible SS changes independent of target-site complementarity by leaving the seed region unchanged. We formulate metrics of the SS differences between such mutants and their wild types (WTs) and test whether disease-associated mutations tend to differ from others in terms of these metrics by comparing our results with the miRNASNP-v3 database. We find that disease-related mutants tend to have a higher probability of being fully unfolded than their WT; this and other SS-related measures are statistically significant at the database level. This is confirmed when we restrict the analysis to the better-validated miRNAs encoded by genes that appear in the manually curated MiRGeneDB database. With the same approach, we identify a subset of individual miRNAs for which SS changes are most likely to be related to disease. These are hsa-miR-1269b, hsa-miR-4537, hsa-miR-4477b, hsa-miR-4641, and hsa-miR-6821-3p; when focusing on the higher-confidence MiRGeneDB miRNAs, we find that hsa-miR-485-5p and hsa-miR-1908-3p are the ones for which SS changes are most likely to be linked to disease. In addition, we show that there are pairs of known miRNA WTs differing only by disease-related point mutations outside the seed region that exhibit very different SS. These pairs include hsa-miR-1269a-hsa-miR-1269b and hsa-miR-3689a-3p-hsa-miR-3689b-3p.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.